ProfileGDS4718 / 212422_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 76% 71% 71% 73% 71% 81% 84% 73% 70% 71% 75% 72% 80% 81% 81% 75% 71% 76% 80% 67% 72% 71% 71% 73% 73% 77% 68% 78% 75% 81% 78% 81% 71% 74% 74% 82% 78% 72% 68% 72% 73% 81% 75% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4477176
GSM549102patient 115, normal, homogenized [OPG study]6.9026971
GSM549104patient 119, normal, homogenized [OPG study]7.0547371
GSM549108patient 138, normal, homogenized [OPG study]7.0709573
GSM549119patient 077, normal, homogenized [OPG study]6.9050371
GSM549133patient 032, cancer, homogenized [OPG study]8.0658981
GSM549139patient 042, cancer, homogenized [OPG study]8.3263584
GSM549099patient 107, normal, homogenized [OPG study]7.0636873
GSM549109patient 139, normal, homogenized [OPG study]6.8819970
GSM549110patient 046, normal, homogenized [OPG study]6.9688771
GSM549114patient 063, normal, homogenized [OPG study]7.329475
GSM549122patient 082, normal, homogenized [OPG study]7.0848772
GSM549134patient 033, cancer, homogenized [OPG study]7.8751980
GSM549136patient 036, cancer, homogenized [OPG study]8.0415481
GSM549140patient 044, cancer, homogenized [OPG study]8.0663881
GSM549111patient 047, normal, homogenized [OPG study]7.3679275
GSM549113patient 057, normal, homogenized [OPG study]6.9743871
GSM549132patient 031, cancer, homogenized [OPG study]7.4632276
GSM549137patient 038, cancer, homogenized [OPG study]7.8699480
GSM549142patient 047, cancer, homogenized [OPG study]6.6338467
GSM549100patient 110, normal, homogenized [OPG study]7.027872
GSM549107patient 135, normal, homogenized [OPG study]6.9613271
GSM549115patient 068, normal, homogenized [OPG study]7.0345871
GSM549116patient 072, normal, homogenized [OPG study]7.14173
GSM549120patient 078, normal, homogenized [OPG study]7.1629373
GSM549131patient 030, cancer, homogenized [OPG study]7.6177877
GSM549118patient 074, normal, homogenized [OPG study]6.7189968
GSM549129patient 027, cancer, homogenized [OPG study]7.6877678
GSM549123patient 088, normal, homogenized [OPG study]7.3188475
GSM549124patient 006, cancer, homogenized [OPG study]7.8775481
GSM549126patient 015, cancer, homogenized [OPG study]7.6279378
GSM549128patient 025, cancer, homogenized [OPG study]8.0181281
GSM549103patient 117, normal, homogenized [OPG study]6.8930171
GSM549117patient 073, normal, homogenized [OPG study]7.1709474
GSM549138patient 041, cancer, homogenized [OPG study]7.3230374
GSM549141patient 045, cancer, homogenized [OPG study]8.2381282
GSM549130patient 028, cancer, homogenized [OPG study]7.6210678
GSM549101patient 111, normal, homogenized [OPG study]7.0022172
GSM549105patient 128, normal, homogenized [OPG study]6.7406268
GSM549106patient 134, normal, homogenized [OPG study]7.1895672
GSM549112patient 048, normal, homogenized [OPG study]7.1062973
GSM549125patient 011, cancer, homogenized [OPG study]7.9069581
GSM549127patient 024, cancer, homogenized [OPG study]7.4619475
GSM549135patient 035, cancer, homogenized [OPG study]8.7063986